Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
HAE Key Statistics
Stock Snapshot
As of today, Haemonetics(HAE) shares are valued at $82.92. The company's market cap stands at 3.98B, with a P/E ratio of 23.93.
On 2026-01-12, Haemonetics(HAE) stock traded between a low of $81.64 and a high of $83.39. Shares are currently priced at $82.92, which is +1.6% above the low and -0.6% below the high.
Haemonetics(HAE) shares are trading with a volume of 493.31K, against a daily average of 505.18K.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $87.32 and a 52-week low of $47.32.
In the last year, Haemonetics(HAE) shares hit a 52-week high of $87.32 and a 52-week low of $47.32.
HAE News
Barrington raised the firm’s price target on Haemonetics (HAE) to $93 from $90 and keeps an Outperform rating on the shares after the company announced that it...
Haemonetics Corporation (NYSE:HAE) on Friday said it will acquire Ireland-based Vivasure Medical Limited, a move aimed at strengthening its position in structur...
Claim 70% Off TipRanks Premium Haemonetics ( (HAE) ) has provided an announcement. On January 9, 2026, Haemonetics Corporation announced it had acquired Vivas...
Analyst ratings
58%
of 12 ratingsMore HAE News
(RTTNews) - Haemonetics Corp. (HAE), a medical technology company, on Friday announced it has acquired Vivasure Medical Ltd., a Galway, Ireland-based developer...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvi...
